Boeing at $232: A Turnaround You Price on Recovery

Boeing trades at 92 times trailing earnings. That number is worthless, and if you anchor on it you’ll misread this stock completely.

Here’s why. A price-to-earnings ratio only means something when earnings are normal. Boeing’s aren’t. The company just clawed its way from a $11.8 billion net loss in 2024 to a $2.24 billion profit in 2025, on record revenue of $89.5 billion. When a company earns almost nothing relative to what it eventually should, its P/E goes to the moon by arithmetic, not because the stock is expensive. Divide a huge price by a tiny sliver of earnings and you get a scary multiple that tells you nothing. This is the trough-earnings trap, run in reverse: the same math that makes a cyclical look cheap at the top makes a recoverer look absurd at the bottom.

So the whole exercise with Boeing is different from valuing a steady compounder. You don’t ask “what does it earn today?” The answer is roughly nothing, and the stock isn’t priced on today. You ask: can it execute the production ramp back to normalized free cash flow, and delever before the balance sheet forces its hand? That’s the bet. Everything else is detail. Every figure below is pulled from Boeing’s own statements as of July 8, 2026; I’ve flagged where the standard valuation tools simply break on a company like this.

#The recovery arc is the whole story

Let me start with the picture that matters, because Boeing is not a business you understand from a snapshot. You understand it from the trajectory.

Return on invested capital is where I always start, because it answers the one question that decides whether a business is worth owning: does a dollar put to work come back as more than a dollar? For a healthy company you want to see ROIC comfortably above the cost of capital, year after year. That gap is value creation.

Boeing fails that test today. And that’s the point.

i

×

A recovery arc, not a moat erosion

This is return on invested capital plotted against the ~8.7% cost of capital (the dashed line). For most companies I profile, the story is a line that sits high above the reference for years — the fingerprint of a durable advantage. Boeing is the opposite case: a line clawing its way up from deep below the hurdle.

The 2024 bottom of -21% is the quality crisis, the machinists’ strike, and multibillion-dollar charges on the 737 and 777X programs all landing in one year. The 2025 print of +6.1% is the first positive reading in a long while. That direction — from -21% to +6% in twelve months — is the recovery made numerical.

But read the chart honestly: +6.1% is still below the 8.7% line. Boeing is not yet earning its cost of capital. This is not a company that has proven it creates value; it is one betting that normalizing production volume will push these returns over the hurdle. That is the inverse of a moat-erosion chart — a business climbing toward the line rather than sliding away from it. Whether it crosses is the thesis.

Notice how differently this reads from a compounder. When Microsoft’s ROIC dips, it’s denominator inflation from a capex build — the business is fine, the accounting lags. When Boeing’s ROIC is below the line, it’s because the business genuinely wasn’t working: planes weren’t shipping, charges were piling up, cash was pouring out. The recovery isn’t a data artifact. It’s an operational fact that either continues or doesn’t.

#What broke, and what’s mending

The clearest way to see a turnaround is to put profitability and cash on the same timeline. One tells you whether the business is earning; the other tells you whether it’s surviving. In a crisis they diverge violently, and Boeing’s 2024 is a textbook example.

i

×

The 2024 cliff, and the 2025 climb out

The left axis is operating margin; the right axis is free cash flow in dollars. Watch 2024: both lines fall off a cliff together. A -16.1% operating margin and a $14.4 billion cash burn in a single year. That is what a machinists’ strike plus program charges plus a quality-and-certification crisis does to an aircraft maker — production halts, but the fixed cost base and the cash outflows don’t.

Now watch 2025. Operating margin snaps back to +4.8% and the cash burn narrows to $1.9 billion. Both lines turn hard in the right direction at once, which is exactly the signature of a genuine operational recovery rather than a one-off accounting swing.

Two cautions keep this honest. First, +4.8% is well short of the ~10%-plus margin Boeing earned before the crisis — there is a long way still to run. Second, free cash flow is still negative. The recovery is visible and directional, but it is not finished. The chart shows a company climbing out of a hole, not one standing on level ground.

That 2024 trough deserves a moment. Operating income of negative $10.7 billion. A net loss of $11.8 billion. Fourteen and a half billion dollars of cash out the door. Boeing has been in existence since 1916, and 2024 was one of the worst financial years in its history, driven by the fallout from the January 2024 Alaska Airlines door-plug blowout, the resulting FAA scrutiny and production caps, charges on the 737 and 777X programs, and a costly machinists’ strike late in the year.

Then 2025: record revenue, a return to profit, positive operating margin. The planes started moving again.

#The cash burn was the emergency. It’s easing.

Revenue was never really Boeing’s problem. The order book has been full for years. The problem was converting orders into delivered aircraft and delivered aircraft into cash. So the revenue-versus-cash chart is the one that shows whether the machine is actually working.

i

×

Record sales, cash flow still catching up

The tall bars are revenue; the short ones (dipping below zero in 2024 and 2025) are free cash flow. The gap between them is the whole turnaround problem in one image. Boeing sold a record $89.5 billion of product in 2025 yet still consumed $1.9 billion of cash.

How? Building aircraft ties up enormous working capital — inventory sits on the balance sheet for months as jets are assembled, and progress payments don’t perfectly match the cash going out. During a ramp, that working-capital drag is severe: you’re spending to build planes faster than the cash comes back. In 2022–23 Boeing generated positive FCF at lower revenue; the burn came when the crisis forced production down and costs stayed up.

The bull read: as deliveries stabilize at higher rates and the working-capital pig moves through the python, cash conversion should normalize and FCF should turn firmly positive. The bear read is worse than the -$1.9B headline. On a stricter owner-earnings basis (EBITDA less maintenance capex, net interest, taxes, and the working-capital change), Boeing burned roughly -$4.8 billion in 2025, because interest expense (~$2.8B) and still-negative EBITDA drag the figure below the reported cash-flow-statement number. Both point the same direction, but the harsher measure says the hole the business has to climb out of is deeper than the standard FCF suggests. Every quarter of burn is another quarter of leaning on a stretched balance sheet, which is why the balance sheet is the next thing to look at.

#The balance sheet is the constraint, stated plainly

This is the part of the Boeing story that keeps sober investors up at night, and it deserves neutral, factual treatment rather than drama.

i

×

Which debt number, and which one goes into the valuation

The bars show the headline consolidated figures: total borrowings drifting around $54 billion and pure cash and equivalents falling to about $11 billion. But there are two ways to count this, and the gap matters more than the claimed margin of safety, so let me reconcile them.

The consolidated view (the bars) is ~$54.4B debt / ~$10.9B cash. The view I use for valuation is narrower: ~$49.6B debt against ~$20.2B of cash AND short-term marketable securities, which nets to $29.4 billion of net debt. Two differences drive the ~$14B swing between a ~$43B and a ~$29B net-debt figure. First, Boeing parks roughly $9B in short-term investments that are cash-like and should count against the debt. Second, the higher gross figure includes Boeing Capital (BCC) customer-financing debt, which is arguably self-liquidating: it is borrowed against finance receivables (aircraft leases and loans) that generate their own cash to repay it, so netting it 100% against the equity thesis overstates the burden. I use $29.4B net debt in the bridge below and flag that even that may be conservative.

On coverage: operating income divided by interest expense sits at roughly 1.5x. A healthy industrial runs 5x or higher. At 1.5x, nearly all of the operating profit Boeing just started generating is eaten by interest, and the quick ratio of 0.32 says the same about near-term liquidity. The usual net-debt-to-EBITDA gauge reads a nonsensical -9x because EBITDA is still negative — the distortion itself is the tell that this balance sheet can only be judged normal once earnings do.

I want to be careful with tone here. A stressed balance sheet is a fact about the numbers, not a verdict on the people. Boeing didn’t lever up out of recklessness; it borrowed to survive a genuine external and self-inflicted crisis, which was the rational move at the time. But the consequence is a real constraint on the equity thesis today.

The liability schedule is where that constraint gets concrete, and for a distressed name the maturity wall is part of the thesis. Boeing has meaningful debt coming due across 2026-2028: several billion dollars per year of maturities that either get repaid from cash, refinanced at prevailing rates, or rolled. Refinancing today means issuing into a market that prices Boeing at roughly BBB-/Baa3, one notch above high yield (Moody’s, S&P Global Ratings). That rating is the hinge. A downgrade to junk would raise the cost of the entire debt stack, shrink the pool of investors who can hold the paper, and is itself a solvency trigger, since some covenants and counterparties treat a junk rating as an event. So the recovery isn’t only about earning more; it’s about clearing near-term maturities and defending the investment-grade rating long enough for cash generation to do the deleveraging. If the recovery stalls and the burn resumes, the company either raises equity (diluting shareholders at a low price), sells assets, or stretches suppliers. The balance sheet is why execution isn’t just about upside; it’s about downside protection too.

#Capital allocation: there isn’t any, and that’s correct

Here’s a section that would normally have a chart. For Boeing, it’s blank, and the blankness is informative.

Boeing pays no dividend. It suspended the payout in March 2020 and has not restored it. It isn’t buying back stock. Every dollar of internally generated cash, and then some, is going toward one of two things: funding the production ramp (working capital, capex to stabilize the factories) and servicing or reducing debt. This is a company in survival-and-repair mode, and the capital-allocation “strategy” is simply: don’t run out of money, get the planes flying, fix the balance sheet.

That’s the right call. A turnaround that pays a dividend or buys back stock while burning cash and carrying 1.5x interest coverage would be allocating capital backwards. The absence of shareholder returns isn’t a knock here; it’s discipline. The signal to watch is the reverse: the day Boeing announces it’s restoring the dividend or authorizing a buyback will be management telling you they believe the balance sheet is repaired and cash generation is durable. That announcement, whenever it comes, is a milestone worth more than the payout itself.

#Why every standard valuation tool breaks here

Now the fun part. If you feed Boeing into a normal valuation model, the model returns garbage. This is worth showing, because it’s exactly why the “92x P/E, sell” and the “cheap on price-to-sales, buy” takes are both lazy.

i

×

Four multiples, four different lies

Trailing P/E of 92x and forward P/E of 55x look terrifying — until you remember the denominator is depressed. Boeing earned $2.2 billion on $89.5 billion of sales, a ~2.5% net margin against a business that historically earns high single digits to low double digits. Divide the price by a temporarily tiny profit and you manufacture a huge multiple. This is the trough-earnings trap inverted: on a recoverer, high P/E can mean cheap, not expensive.

Price-to-book of 30.5x is even more broken. Book value (equity) was nearly wiped out — it was actually negative from 2022 through 2024 after years of losses, and clawed back to just $5.4 billion in 2025. Divide a $183 billion market cap by a sliver of equity and P/B explodes. It tells you the balance sheet was gutted, which you already knew; it tells you nothing about value.

Price-to-sales of 2.0x is the only one that half-works, because revenue didn’t collapse the way profit and equity did. But even it needs a margin assumption to mean anything. The lesson: you cannot value Boeing on any trailing multiple. You have to normalize — estimate what it earns and generates in cash once production is running properly — and value that.

Look at the reverse-DCF, the tool I usually lead with. It’s supposed to tell you what growth rate the current price implies. For Boeing, the model returns nothing usable, because you can’t compound a growth rate off a negative starting free cash flow. The forward DCF does the same: negative starting FCF, no fair value. The models don’t fail because Boeing is worthless. They fail because a discounted-cash-flow engine needs positive cash flow to discount, and Boeing doesn’t have it yet. That’s the definition of a turnaround: the value is entirely in cash flows that don’t exist today but plausibly will.

#So what’s it actually worth? Value the recovery.

If trailing multiples lie and the DCF won’t run, you value Boeing the way you value any turnaround: estimate normalized earnings and free cash flow — what the business generates once it’s running at a healthy, sustainable production rate — and value that stream, then discount for the risk that it doesn’t get there.

Before the anchors, the normalization has to be earned segment by segment, because Boeing isn’t one business. Commercial Airplanes is where the margin recovery lives: return the 737 and 787 to normal build rates and the crisis-era charges fall away, carrying this segment from loss back toward its historical high-single-digit margin. Global Services is already healthy — high-margin aftermarket parts and maintenance that never really broke. The overhang sits in Defense, Space & Security (BDS): a cluster of fixed-price development contracts (KC-46 tanker, VC-25B Air Force One, T-7, MQ-25, Starliner) where Boeing eats cost overruns, and where it has taken repeated multibillion-dollar charges. Normalized BDS margin is a genuine question mark — the bull assumes the charge cycle is ending and the segment returns to low-to-mid single digits; the bear assumes fresh charges keep landing. My normalized ~$10B FCF anchor assumes Commercial recovers, Services holds, and BDS stops bleeding but doesn’t become a star. If BDS keeps taking charges, the base case slips.

The anchors I’d use, all netting the $29.4B net-debt figure reconciled above, all triangulating the same place:

Method	Normalized assumption	Implied value per share
Normalized FCF	~$10B FCF (Street/mgmt ~2027–28) × 18x EV/FCF, less $29.4B net debt	~$190
Normalized FCF (haircut)	~$10B FCF × ~14x (distressed-name multiple), less net debt	~$140
Normalized FCF (bull)	~$13B FCF × 18x, less net debt	~$260
EV / sales	~$100–112B sales × ~2.0x EV/S	~$215–250
Normalized EPS	~$10 EPS × ~20x	~$200
Analyst mean (25 analysts)	Consensus target	$270.44

That’s a blended intrinsic range of roughly $190 to $260, with the analyst consensus sitting a touch above at $270. Note the haircut row: if you refuse to pay a clean-compounder 18x for a company that still burns cash and carries 1.5x coverage, and instead apply a distressed 14-15x, the base case drops toward $140 — below today’s price. The multiple you’re willing to pay on normalized cash is itself a big swing factor, and the market is clearly paying up for the recovery landing. The current price of $231.68 lands in the upper-middle of the honest range.

Intrinsic value · the verdict

Blended fair value

$230

Current price

$232

Margin of safety

-1%

i

×

What you're looking at & why it matters

Free cash flow is the cash left after operating costs and capital spending — the money truly available to owners for buybacks, dividends, debt paydown, or acquisitions. Unlike accounting earnings it's hard to fake, which is why it anchors any serious valuation.

Each dot is a fair-value-per-share estimate from a different method; the dashed vertical line is today's market price. Dots to the right imply upside on that method; dots to the left mean the price is already ahead of it.

The methods disagree on purpose — a multiple built on a depressed-cash-flow year lands low, a growth DCF lands high. The honest answer is the range between them, not any single point.

Why it matters: seeing every method at once, against the price, keeps the valuation honest — it exposes how much of the outcome rides on the growth assumption instead of hiding behind one false-precise target.

Fair values from multiple methods (see above). Source: Yahoo Finance + author normalized-earnings estimates · as of July 2026. Illustrative, assumption-driven, not a price target.

One number I owe you before the read: the finance-service model spits out a mechanical fair value of $180 per share, a -22% margin of safety versus the current price. I’m deliberately overriding it upward to a ~$230 midpoint, and you should know why rather than take my number on faith. That $180 is an average of multiple-based methods that are broken on a company like this: it applies today’s distorted trailing and forward multiples (a 55x forward P/E, a negative EV/FCF, a negative EV/EBITDA) to trough metrics, then averages the wreckage. It’s the same trap I spent the whole valuation section warning against, just automated. My normalized anchors deliberately look through the trough to what the business earns at healthy production rates. But the model’s $180 is a useful gut-check in one direction: it says if you don’t believe the normalization, there’s real downside, and the honest low end of my range (the $140 haircut case) isn’t far from it.

There’s a harder downside anchor still, and it’s the one that makes this an option, not a bond. If the recovery stalls and free cash flow stays negative through 2027, Boeing very plausibly raises equity to shore up the balance sheet. A $10 billion raise at, say, ~$180 per share would issue roughly 55 million new shares on ~788 million outstanding, about 7% dilution, and it would likely come at a depressed price precisely because the recovery had disappointed. That’s the mechanism by which the equity behaves like a call option on the turnaround: enormous upside if production and cash normalize, but a real path where existing holders get diluted at the bottom. You’re not buying a claim on stable cash flows; you’re buying a levered bet on the ramp, with the balance sheet as the strike price.

So here’s the honest read. At $232, the market is not pricing Boeing as a broken company, and it’s not pricing it as a fully healed one either. It’s pricing in a successful-but-not-yet-complete recovery. You are paying roughly fair value for the base case that Boeing gets back to ~$10 billion of free cash flow and normal margins over the next couple of years. There’s no obvious margin of safety versus my intrinsic estimate — the price sits right on it, and versus the model’s $180 you’re paying a premium. Versus the $270 analyst mean there’s a modest ~15% cushion, but consensus is itself betting on the recovery landing.

Which means the whole thing reduces to one sentence. The bet on Boeing is not about valuation multiples; it’s about execution: can the company ramp 737 and 787 production to normalized rates, turn free cash flow durably positive, and delever — before the stressed balance sheet forces a bad decision? Get that right and the bull anchors (backlog, duopoly, margin recovery) pull it toward $260-plus. Get it wrong and the balance sheet, not the income statement, writes the ending.

#The duopoly is the reason to bother at all

Why give a loss-strewn, debt-laden company the benefit of the doubt? Because of what it is. Boeing and Airbus are the entire global market for large commercial jets. That’s it. Two companies. If an airline needs a few hundred narrowbodies, it has exactly two phone numbers to call, and Airbus’s order book is booked out for years. That structure is an extraordinary moat — it’s just been buried under Boeing’s self-inflicted operational wounds.

The evidence is in the backlog. Boeing sits on a commercial backlog north of $500 billion — years of contracted demand, orders customers have already committed to. The demand isn’t the question. Airlines want the planes. The question is purely whether Boeing can build them, safely and on schedule, and get paid. Layer on the Defense, Space & Security segment and Global Services (high-margin aftermarket parts and maintenance on a huge installed base), and you have real ballast under the volatile commercial business.

A moat that produces a duopoly with a half-trillion-dollar backlog is why a recovery is even plausible. The customers are captive. The product is essential. The only broken part is the factory, and factories can be fixed.

#Tailwinds and headwinds, weighed honestly

Every dollar of the bull case runs through execution. Every dollar of the bear case runs through the balance sheet and Boeing’s track record of missing its own timelines. Let me lay both out.

Tailwinds (the bull case):

• Contracted demand. A ~$500B+ commercial backlog means revenue is largely pre-sold. Boeing doesn’t need to win the market; it already has, structurally. It needs to deliver.
• Margin recovery runway. At +4.8% operating margin against a historical ~10%-plus, there’s a lot of room to climb simply by returning to normal production efficiency and shedding crisis-era charges.
• Duopoly pricing power. With Airbus capacity-constrained and only two suppliers on earth, Boeing has structural pricing and demand support that few industrials enjoy.
• The cash inflection. FCF burn narrowed from $14.4B to $1.9B in a year. If the 737 MAX ramp toward the low-40s per month and the 787 ramp hold, the Street models free cash flow turning firmly positive and heading toward ~$10 billion by 2027–28. That’s the number that repairs the balance sheet.

Headwinds (the bear case):

• The balance sheet and the maturity wall. ~$29.4B net debt (reconciled above), 1.5x interest coverage, and several billion dollars of maturities coming due each year across 2026-2028 that must be repaid or refinanced. The credit rating sits at roughly BBB-/Baa3, one notch above junk; a downgrade raises the cost of the whole stack and is itself a solvency trigger. A stalled recovery could force a dilutive equity raise (a ~$10B raise near $180 would be ~7% dilution at a bad price) or asset sales. On a stricter owner-earnings basis, 2025’s burn was closer to -$4.8B than the reported -$1.9B.
• Execution and Boeing’s own record. This is material and I’ll state it factually: Boeing has repeatedly missed its own production-rate and cash-flow timelines over the past several years. Every prior “we’ll be at rate X by date Y” has tended to slip. That history is a reason to apply a real haircut to current guidance, not to take the recovery trajectory as a straight line.
• Regulatory and quality risk. The FAA capped 737 MAX production after the 2024 door-plug incident. Production rate increases require regulatory sign-off tied to demonstrated quality and safety. Another quality escape resets the clock and the trust.
• Cash flow is still negative. For all the improvement, Boeing consumed cash in 2025. The recovery is directional, not complete, and the thesis requires it to finish.

On the timeline-credibility point especially: because live transcript access was unavailable at the time of writing, I’m relying on the reported financials and Boeing’s public track record rather than fresh call quotes. Boeing next reports on July 28, 2026 — the production rates (737 toward the low-40s per month, 787 ramp), the cash-flow-turn timing, any fresh defense-program charges, and FAA commentary are the exact items to check against what management has promised before. Treat the guide with skepticism earned by history.

#The one thing to watch

Forget the P/E. Forget, even, the quarterly revenue beats. There is exactly one number that decides whether Boeing at $232 works out: the quarter free cash flow turns durably, structurally positive. That’s the moment the recovery stops being a hope discounted into the price and starts being a fact that repairs the balance sheet, restores the option of returning capital, and lets ROIC climb decisively over that 8.7% line.

Until that quarter arrives, everything is trajectory and trust. The duopoly guarantees the demand. The backlog guarantees the orders. Neither guarantees the cash. And a company with 1.5x interest coverage doesn’t get unlimited time to prove it can generate the stuff.

What’s your read — is Boeing’s recovery far enough along to be worth the balance-sheet risk, or is the market pricing the turnaround as complete before the cash flow confirms it? I’d genuinely like to hear the bear case. Come argue with me on X or LinkedIn.

Keep reading: if you want the mirror image of this analysis — a company whose free cash flow looks weak but for the opposite reason (a deliberate capex build, not a crisis) — see my breakdown of why the market may be misreading Microsoft as a hyperscaler. For a deep-cyclical where the trick is normalizing through the cycle rather than through a recovery, there’s ASML and the EUV monopoly. Or browse the full Finance category for more valuation breakdowns.

Research note: financial data is from Yahoo Finance (via the finance-service snapshot), as of July 8, 2026, cross-checked against Boeing’s reported FY2025 figures. The valuation nets $29.4B of net debt (the reconciled figure: ~$49.6B narrower debt against ~$20.2B of cash and short-term investments), which differs from the ~$54.4B/$10.9B consolidated debt-and-cash shown in the balance-sheet chart; Boeing Capital customer-financing debt is arguably self-liquidating and not fully attributable to the equity. The finance-service model’s mechanical fair value is $180 (a -22% margin of safety); I override it to a ~$230 midpoint because that model averages trailing/forward multiples that are distorted on a trough-earnings recoverer — my normalized-FCF, EV/sales, and normalized-EPS anchors are the author’s estimates, illustrative, not price targets. Credit-rating (~BBB-/Baa3) and maturity-schedule details are directional and should be confirmed against Boeing’s filings and the rating agencies. Standard DCF and reverse-DCF outputs are omitted because negative starting free cash flow makes them non-computable — itself a signature of the turnaround archetype. Live earnings-call transcript access was unavailable at the time of writing, so no verbatim management quotes are included and forward context is qualitative; verify production-rate, cash-flow, maturity, and rating figures against Boeing’s July 28, 2026 report and its primary filings (10-K/10-Q, SEC EDGAR) before relying on any figure.